Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies

Freites Martínez, Azael DavidSantana Rodríguez, N.Arias Santiago, SalvadorViera Ramírez, Agustín2023-03-282023-03-282021Freites-Martínez, A., Santana, N., Arias-Santiago, S., & Viera, A. (2021). Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies. Actas Dermo-Sifiliográficas (English Edition), 112(1), 90–92. https://doi.org/10.1016/j.ad.2019.05.0092173-5778http://hdl.handle.net/11268/11967engAntineoplásicosFenómenos fisiológicos de la pielUsing the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer TherapiesCTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicasjournal article10.1016/j.ad.2019.05.009open accessCáncerTratamiento médicoEfectos fisiológicos